Korro Bio
KRRO
88 hedge funds and large institutions have $135M invested in Korro Bio in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 33 reducing their positions, and 12 closing their positions.
28% more call options, than puts
Call options by funds: $1.54M | Put options by funds: $1.2M
0.05% less ownership
Funds ownership: 1.14% → 1.09% (-0.05%)
3% less funds holding
Funds holding: 91 → 88 (-3)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
30% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 33
32% less capital invested
Capital invested by funds: $198M → $135M (-$63.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$4.13M |
| 2 |
BlackRock
New York
|
+$953K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$643K |
| 4 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
+$513K |
| 5 |
Walleye Capital
New York
|
+$416K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
-$3.93M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.74M |
| 3 |
Millennium Management
New York
|
-$1.88M |
| 4 |
Morgan Stanley
New York
|
-$1.46M |
| 5 |
JP Morgan Chase
New York
|
-$1.27M |
KRRO Hedge Fund Activity: Q3 2021 in Review
88 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2021, worth a combined $135M — down 32% from $198M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of KRRO and 9 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 23 added.
The largest buyer was Federated Hermes, adding an estimated $4.13M. The largest seller was Amundi, cutting an estimated $3.93M.
- 88 institutional investors held Korro Bio (KRRO) as of Q3 2021, down from 91 in Q2 2021.
- Funds reported $135M of Korro Bio stock for Q3 2021, down 32% quarter-over-quarter.
- 9 funds opened new Korro Bio positions in Q3 2021 and 12 closed out, a net change of -3 holders.
- The largest Korro Bio buyer in Q3 2021 was Federated Hermes, an estimated $4.13M added.
- The largest Korro Bio seller in Q3 2021 was Amundi, an estimated $3.93M sold.
Based on aggregated 13F filings for Q3 2021.